Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA approves Calypte's HIV Western blot urine test:

This article was originally published in Clinica

Executive Summary

The US FDA has approved Calypte Medical's PMA application for the Cambridge Biotech HIV-1 Urine Western Blot. The product is intended to be used as a supplementary, more specific test for urine samples found to be positive for HIV-1 antibody using the company's EIA screening procedure. Among the benefits of the new regulatory status is the ability to extend the product's expiration dating, which should improve manufacturing efficiency and facilitate supply to international markets, says the Alameda, California firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072151

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel